| Name | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(2,2,3,3,5,5,6,6-octadeuteriomorpholin-4-yl)propoxy]quinazolin-4-amine |
|---|---|
| Synonyms |
Gefitinib D8Q: What is Gefitinib D8 Q: What is the CAS Number of Gefitinib D8 Q: What is the storage condition of Gefitinib D8 Q: What e the applications of Gefitinib D8
ZD1839 D8 D8-Gefitinib N-(3-chloro-4-fluorophenyl)-7-methoxy-6-{3-[(2,2,3,3,5,5,6,H)morpholin-4-yl]propoxy}quinazolin-4-amine [2H8]-Gefitinib Gefitinib-d8 DISCONTINUED. Please see G304008 |
| Description | Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 37 nM (Tyr1173 site, in NR6wtEGFR cells), 37 nM (Tyr992 site, in NR6wtEGFR cells)[1] |
| References |
| Molecular Formula | C22H16D8ClFN4O3 |
|---|---|
| Molecular Weight | 454.95200 |
| Exact Mass | 454.20200 |
| PSA | 68.74000 |
| LogP | 4.28650 |